Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001737287-25-000064
Filing Date
2025-05-13
Accepted
2025-05-13 16:07:36
Documents
83
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q allo-20250331.htm   iXBRL 10-Q 1300341
2 EX-10.1 allo-20250331xex101.htm EX-10.1 40159
3 EX-10.4 allo-20250331xex104.htm EX-10.4 429008
4 EX-10.5 allo-20250331xex105.htm EX-10.5 86234
5 EX-10.6 allo-20250331xex106.htm EX-10.6 155874
6 EX-31.1 allo-20250331xex311.htm EX-31.1 9782
7 EX-31.2 allo-20250331xex312.htm EX-31.2 9747
8 EX-32.1 allo-20250331xex321.htm EX-32.1 7005
14 image_0a.jpg GRAPHIC 136
15 image_0b.jpg GRAPHIC 19780
16 image_1a.jpg GRAPHIC 10746
17 image_2a.jpg GRAPHIC 154
  Complete submission text file 0001737287-25-000064.txt   7513897

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allo-20250331.xsd EX-101.SCH 53491
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allo-20250331_cal.xml EX-101.CAL 57651
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allo-20250331_def.xml EX-101.DEF 296553
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allo-20250331_lab.xml EX-101.LAB 662929
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allo-20250331_pre.xml EX-101.PRE 476313
85 EXTRACTED XBRL INSTANCE DOCUMENT allo-20250331_htm.xml XML 705591
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38693 | Film No.: 25940041
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)